Chetan Mehta's most recent trade in Aarey Drugs & Pharmaceuticals Ltd. was a Acquisition of 300,000 Equity Shares done at an average price of Rs. 41.2 . Disclosure was reported to the exchange on Dec. 14, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Chetan Mehta's has made SAST transactions in Worth Investment and Trading Company Ltd. recently where a Acquisition of 15,270,540 shares done . Disclosure was reported to the exchange on Nov. 19, 2024.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Worth Investment
|
Chetan Mehta | Other | Acquisition | 26 Nov 2024 | 15,270,540 | 25,450,900 (6.86%) | 4.11% | - | 18 Nov 2024 18 Nov 2024 |
SAST (29(2)) | - | Allotment | |
Worth Investment
|
Chetan Mehta | Other | Acquisition | 17 Oct 2024 | 1,000 | 1,019,036 | - | - | 11 Sep 2024 11 Sep 2024 |
SAST (29(2)) | - | Market | |
Worth Investment
|
Chetan Mehta | Other | Acquisition | 24 Apr 2024 | 400,000 | 1,018,036 (6.87%) | 2.67% | - | 18 Apr 2024 18 Apr 2024 |
SAST (29(2)) | - | Allotment | |
Worth Investment
|
Chetan Mehta | Other | Acquisition | 07 Dec 2023 | 368,000 | 618,036 (4.17%) | 2.48% | - | 29 Nov 2023 29 Nov 2023 |
SAST (29(2)) | - | Allotment | |
Aarey Drugs & Pharma
|
Chetan Mehta | Director | Acquisition | 14 Dec 2021 | 300,000 | 300,000 (1.18%) | 1.28% | 41.2 | 12,348,000 | 25 Nov 2021 25 Nov 2021 |
Insider Trading | Equity Shares | Allotment |
Candour Techtex
|
Chetan Mehta | Other | Disposal | 17 Oct 2020 | 1,122,505 | 698,821 (4.33%) | 6.96% | - | 16 Oct 2020 16 Oct 2020 |
SAST (29(2)) | - | Market |